Pharmaceuticals The most-up-to-date pharmaceutical news stories, including medical, cosmetic, and supplemental treatments. This section contains releases covering all aspects of the pharmaceutical sector, from research, development, and testing, through to product launches and marketing. Topics include clinical trials and studies, as well as updates on the FDA approval process for new treatment options. Learn about upcoming events, conferences, and educational initiatives. Also included is financial and corporate information from the sector, such as board decisions, appointments and changes, industry awards, and quarterly reports.

Latest

Feb 16, 2017, 14:00 ET Aralez to Present at the RBC Capital Markets Global Healthcare Conference

Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ) (TSX: ARZ), a global specialty pharmaceutical company, today announced that executive management will...


Feb 16, 2017, 12:41 ET AbbVie Declares Quarterly Dividend

The board of directors of AbbVie Inc. (NYSE: ABBV) declared a quarterly cash dividend of $0.64 per share. The cash dividend is payable May 15,...


Feb 16, 2017, 12:16 ET SmartCEO Executive Management Award presented to Dr. Sid Bhoopathy

Absorption Systems, a global leader in nonclinical testing of drugs, biologics, and medical devices, is pleased to announce that its Chief...


Feb 16, 2017, 12:00 ET Prostacyclin Market Global Competitive Analysis and 2022 Forecasts

Global Prostacyclin Industry 2017 Research Report initially provides a basic overview of the industry that covers definition, applications and...


Feb 16, 2017, 11:25 ET SOCMA Partners with ChemicalInfo to Provide Members with Online Chemical Services Directory

The Society of Chemical Manufacturers & Affiliates (SOCMA) is pleased to announce it is partnering with ChemicalInfo to provide its members...


Feb 16, 2017, 10:23 ET FORTUNE® Recognizes CVS Health on List of "World's Most Admired Companies"

CVS Health (NYSE: CVS), the nation's largest pharmacy innovation company, today was named one of the World's Most Admired Companies by FORTUNE®...


Feb 16, 2017, 10:10 ET Global Antibacterial Drugs Market to 2022: Antibacterial Drug Market will Hit $35.6 Billion by 2022, as Efforts Increase to Tackle Antimicrobial Resistance - Research and Markets

Research and Markets has announced the addition of the "Global Antibacterial Drugs Market to 2022 - Vaccines Retain Market Prominence While...


Feb 16, 2017, 10:03 ET Amygdala Neurosciences Acquires GS-6637 from Gilead Sciences

Amygdala Neurosciences Inc., a biopharmaceutical company focused on the development and commercialization of first-in-class drug candidates for...


Feb 16, 2017, 10:00 ET Global Orthopaedic Imaging Market to be Valued at US$ 12.4 Billion During 2016-2026

Medical organisations and research institutes will continue to put more efforts towards development of advanced imaging devices. Growing...


Feb 16, 2017, 09:00 ET Cocoon Biotech Announces CEO, Dr. Ailis Tweed-Kent, Named to Boston Business Journal's "2017 Women to Watch in Science and Technology" List

Cocoon Biotech, Inc., a biotechnology company focused on the development of osteoarthritis and other drug-delivery therapies based on its silk...


Feb 16, 2017, 08:56 ET With Flu Activity High, Department of Health Reminds Pennsylvanians It's Not Too Late To Get Flu Shot

The Department of Health is reminding everyone in Pennsylvania that there is still time to get immunized against the flu as the number...


Feb 16, 2017, 08:30 ET Medicinal Cannabis Industry Turns Toward Biopharma Influence for Competitive Advantages in Product Development

While the medicinal cannabis industry continues to rapidly advance and expand operations by identifying new leading edge products, leaders are...


Feb 16, 2017, 08:30 ET Regulus Announces Publication in Nature Communications Identifying miR-17 as a Promising Drug Target for ADPKD

Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


Feb 16, 2017, 08:30 ET ANI Pharmaceuticals Schedules Conference Call for Fourth Quarter and Full Year 2016 Financial Results and 2017 Guidance

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced today that the Company plans to release its fourth quarter and full year 2016 financial results...


Feb 16, 2017, 08:08 ET U.S. FDA Accepts Biologics License Application (BLA) for Mylan and Biocon's Proposed Biosimilar Pegfilgrastim for Review

Mylan N.V. (NASDAQ, TASE: MYL) and Biocon Ltd. (BSE code: 532523, NSE: BIOCON) today announced that the U.S. Food and Drug Administration (FDA) has...


Feb 16, 2017, 08:00 ET How These Healthcare Stocks are Faring? -- GlaxoSmithKline, Shire, Pacira Pharma, and Supernus Pharma

On Wednesday, February 15, 2017, the NASDAQ Composite, the Dow Jones Industrial Average, and the S&P 500 edged higher at the closing bell,...


Feb 16, 2017, 08:00 ET Benitec Biopharma to present expanded data set from pivotal data in hepatitis B virus (HBV) in vivo model at International Liver Meeting in Shanghai, China

Benitec Biopharma Limited (ASX: BLT; NASDAQ: BNTC; NASDAQ: BNTCW) today announced that it will present pivotal data from the Company's hepatitis B...


Feb 16, 2017, 08:00 ET Imprimis Pharmaceuticals Begins Dispensing from FDA-Registered 503B Outsourcing Facility

Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), an ophthalmology-focused pharmaceutical company, today announced that it has begun shipping its core...


Feb 16, 2017, 08:00 ET FDA Expands Approval of SPIRIVA® RESPIMAT® (tiotropium bromide) Inhalation Spray for Maintenance Treatment of Asthma in Children

Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) approved SPIRIVA RESPIMAT for the...


Feb 16, 2017, 08:00 ET Dauntless Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Octreotide Formulation for Intranasal Delivery

Dauntless Pharmaceuticals, Inc., a privately held biopharmaceutical company focused on the development of specialty therapeutics, today announced...


Feb 16, 2017, 08:00 ET GluSense Receives Investment From JDRF T1D Fund

GluSense Ltd., a medical device company developing a long lasting injectable glucose sensor for treatment of Type 1 Diabetes (T1D), today...


Feb 16, 2017, 07:52 ET Shire Reports Full Year 2016 Results With Record Revenue; Positioned for Continued Strong Growth Driven by Best-in-class Rare Disease Pipeline

Key growth contributions from all therapeutic areas Baxalta integration progressing ahead of schedule; Shire now the world leader in rare...


Feb 16, 2017, 07:30 ET Denovo Biopharma plans to launch a Global Phase 3 Trial of DB102 (Enzastaurin) in Diffuse Large B-cell Lymphoma

Denovo Biopharma LLC, a leading company in precision medicine announces the plan to initiate a biomarker driven global phase 3 clinical trial for...


Feb 16, 2017, 07:10 ET Global Halal Pharmaceuticals ( Capsules, Tablets & Syrups) Market Analysis & Trends 2016 - Product Type, Drug Classes, Source Material Forecast to 2025 - Research and Markets

Research and Markets has announced the addition of the "Global Halal Pharmaceuticals Market Analysis & Trends - Product Type, Drug Classes,...


Feb 16, 2017, 07:00 ET NanoViricides Files Quarterly Report for Period Ending 2016-12-31

NanoViricides, Inc. (NYSE MKT: NNVC) (the "Company"), filed its quarterly report for its second quarter of financial year 2017 in a timely manner...